Day One Biopharmaceuticals
Pharmaceuticals
Day One Biopharmaceuticals valuation and funding history | Last updated: February 1, 2021 | 1 funding rounds
Current Valuation
N/A
As of February 1, 2021
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series B)
$130.0M
Last Funding
Feb 2021
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| February 1, 2021 | Early Stage VC (Series B) | $130.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Day One Biopharmaceuticals is currently valued at N/A as of February 1, 2021.
Explore More Data
Detailed analysis for Day One Biopharmaceuticals
What is Day One Biopharmaceuticals Worth in 2026?
Day One Biopharmaceuticals is a leading private company in the Pharmaceuticals sector. Track Day One Biopharmaceuticals's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Day One Biopharmaceuticals Valuation is Determined
Private company valuations like Day One Biopharmaceuticals's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.